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Purpose 
To characterize the solid state properties of indomethacin in binary solid dispersions with Gelucire 50/13®. 
Methods 
Solid dispersions (SD) made up of indomethacin and Gelucire 50/13® (15:85) were prepared by dissolving indomethacin in 
molten Gelucire 50/13®, followed by solidification of the mixture. The thermal properties of SD were analyzed using a 
Q2000 MDSC (TA-Instruments). Samples were kept isothermal at 100°C during 5 minutes, followed by cooling to -70°C at 
various cooling rates followed by subsequent heating from −70°C to 170°C at 2°C/min with the temperature modulation of 
±0.64°C every 40 seconds. For X-ray diffraction (XRD) analysis, the samples were mounted on a thermostated sample holder 
unit (Anton Paar), heated to 60°C at a heating rate of 2°C/min, followed by cooling to 25°C at various cooling rates. The 
samples were then analyzed with an automated X’pert PRO diffractometer. The analysis was performed in a continuous scan 
mode in a range 4°≤2θ≤40°. 
Results 
XRD analysis showed that the initial indomethacin was the γ-form, and it was transformed to a new form in SD with Gelucire 
50/13® at slow cooling rate (1-2°C/min). This form of indomethacin exhibited distinct X-ray diffraction peaks at 8.09°, 
10.56°, 12.15° and 16.25° (2θ). 
 
Gelucire 50/13® showes a complex endotherm due to the fusion of the product. The endothermic peak changed significantly 
when varying the cooling rate, suggesting the modification in the folding behavior of Gelucire 50/13®. 
 
The phase diagram of SD of indomethacin and Gelucire 50/13® constructed from DSC data was typical of a monotectic 
system, taking the form of a simple eutectic diagram in which the liquidus curve and the solidus curve have become 
superimposed. One of the liquid branches disappeared and the branch displaying Gelucire 50/13® was replaced with the 
eutectic compound in samples containing up to 25% indomethacin. The liquid branch remained unchanged as the 
indomethacin content increased, indicating that the drug was solubilized in liquid Gelucire 50/13®.  
 
Conclusion 
In this study, SD of indomethacin and Gelucire 50/13® were thoroughly characterized by using DSC and XRD. We observed 
a solid form of indomethacin which displaying Bragg peaks at different 2θ values as those reported before.  
